Skip to main content
TipRanks
Go Ultimate75% OFF

Carl Goldfischer Insider Profile

4 Followers

Carl Goldfischer, Director at Damora Therapeutics, holds 0.00 shares in Epizyme (Ticker: EPZM), holds 29.02K shares in Damora Therapeutics (Ticker: DMRA), holds 703.38K shares in Enliven Therapeutics (Ticker: ELVN).

Carl Goldfischer's Trading History

EPZM
Epizyme
Aug 16, 2022―Uninformative Sell―$0.00
DMRA
Damora Therapeutics
Nov 04, 2020DirectorUninformative Buy―$626.81K
ELVN
Enliven Therapeutics
Mar 16, 2020DirectorUninformative Buy―$34.32M
~RSLS
ReShape Lifesciences
May 26, 2017―Informative Buy22.64K$662.30K
CBAY
CymaBay Therapeutics
Sep 11, 2015―Informative Sell128.15K$0.00
PARD
Poniard Pharmaceuticals
Jun 10, 2011DirectorUninformative Buy――
~MAPP
Map Pharmaceuticals
――――

You May Also Like

Carl Goldfischer insider profile FAQ

What is the percentage of profitable transactions made by Carl Goldfischer?
The percentage of profitable transactions made by Carl Goldfischer is 75%.
What is the average return per transaction made by Carl Goldfischer?
The average return per transaction made by Carl Goldfischer is 4.20%.
What stocks does Carl Goldfischer hold?
Carl Goldfischer holds: DMRA, EPZM, ELVN, ~RSLS, CBAY, ~MAPP, PARD stocks.
What was Carl Goldfischer's most profitable transaction?
Carl Goldfischer’s most profitable transaction was an Informative Sell of EPZM stock on August 25, 2014. The return on the trade was 52.50%.
What is Carl Goldfischer's role in Damora Therapeutics?
Carl Goldfischer's role in Damora Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.